NCT00142454 2022-10-10NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)Ludwig Institute for Cancer ResearchPhase 1 Completed9 enrolled 7 charts
NCT00118313 2020-03-27Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV MelanomaUniversity of VirginiaPhase 1 Completed